Is Organigram Finally a Buy?

: OGI | OrganiGram Holdings Inc. News, Ratings, and Charts

OGI – OrganiGram (OGI) is reducing staff. Is it time to buy.

Last week OrganiGram (OGI) announced that it would be reducing staff by 25% as the COVID-19 pandemic weighs on the industry. The decision to cut staffing will affect approximately 220 employees, including a small number of employees not on temporary layoff. 

The company also plans to move forward with 433 active employees who operate out of its indoor production facility in Moncton, New Brunswick. OGI has a total workforce of 609 employees, including 84 employees who remain on temporary layoff, but may be called back to work.

With its reduced workforce, the company believes that it can continue to meet current and anticipated near-term demand levels.

OrganiGram’s CEO Greg Engel said, “These decisions are never easy to make, but we are committed to ensuring the Company is appropriately sized relative to market conditions – we are incredibly grateful for the commitment that our affected employees have made in helping build the Company that Organigram is today.”

I view the reduction in staff as positive for the company as it adjusts to the current market environment,  I remain optimistic in the long-term for many reasons

First, the company has a healthy balance sheet compared to some of its peers. OGI has very little debt, a strong cash position, and fewer operating expenses than some of its larger competitors with huge facilities. Furthermore, the company will be focusing on 2.0 products with a new production line capable of producing 4 million kgs of edible chocolate per year.

Though layoffs are never pleasant, it is prudent for the company to reduce its size and become leaner and more efficient as the economy faces major headwinds due to the spread of the coronavirus. 


OGI shares were trading at $1.61 per share on Tuesday afternoon, up $0.05 (+3.21%). Year-to-date, OGI has declined -34.29%, versus a -1.04% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
OGIGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


How Low Could Stocks Go?

The S&P 500 (SPY) is starting to test key support levels for the first time since November 2023 given continuing signs that Fed rate cuts are getting pushed further and further into the future. This begs the question of “how low could stocks go?” 44 year investment veteran Steve Reitmeister does his level best to answer that question including a trading plan and top picks to stay one step ahead of the market. Read on below for the full story...

3 Biotech Stocks to Buy to Power Through April

The biotech sector is primed for growth, fueled by a surge in FDA approvals, anticipated M&A deals, and the integration of AI in drug discovery. So, fundamentally sound biotech stocks Theratechnologies (THTX), Harmony Biosciences (HRMY), and Shionogi & Co. (SGIOY) might be solid buys in this month. Keep reading...

Check out These 3 Internet Stocks for Potential Gains

Amplified internet usage, technological advancements, and a rising digital transformation worldwide have driven the internet industry rapidly. To that end, quality internet stocks Wix.com (WIX), Tripadvisor (TRIP), and Yelp (YELP) could be solid buys now. Read on…

Top 3 Financial Services Stocks With Unstoppable Momentum

The financial services sector is set for solid growth owing to global economic trends, technological advancements making digital services more accessible, and changing consumer preferences.Therefore, investors could consider buying fundamentally strong financial services stocks Broadridge Financial Solutions (BR), Banco Macro (BMA), and Yiren Digital (YRD) as they look well-positioned to continue their momentum. Read more...

Updated 2024 Stock Market Outlook

The bull market continues to rage on with the S&P 500 (SPY) making new highs. That is the past...the question is what does the future hold? That is why 44 year investment veteran Steve Reitmeister provides this updated 2024 Stock Market Outlook to help you carve a path to outperformance the rest of the year. Read on below for the full story...

Read More Stories

More OrganiGram Holdings Inc. (OGI) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All OGI News